Human pluripotent stem cell derived midbrainPITX3eGFP/w neurons: A versatile tool for pharmacological screening and neurodegenerative modeling

Frontiers in Cellular Neuroscience

Volumn 9, Issue , 2015, Pages

  Watmuff, Bradley ^a   Hartley, Brigham J ^a   Hunt, Cameron P J ^a   Fabb, Stewart A ^a   Pouton, Colin W ^a   Haynes, John M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Functional characterization; Human embryonic stem cells; In vitro neurodegenerative modeling; Midbrain dopaminergic neurons

Indexed keywords

CHLORIDE ION; TRANSCRIPTION FACTOR PITX3; TUMOR NECROSIS FACTOR; ZINC FINGER NUCLEASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MESENCEPHALON; MOUSE; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NONHUMAN; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; REPORTER GENE; RNA EXTRACTION; SOUTHERN BLOTTING; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 84939816364     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00104     Document Type: Article

References (55)

1. Ben-Ari, Y., Gaiarsa, J. L., Tyzio, R., and Khazipov, R. (2007). GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol. Rev. 87, 1215-1284. doi: 10.1152/physrev.00017.2006
2. Bialecka, M., Klodowska-Duda, G., Kurzawski, M., Slawek, J., Gorzkowska, A., Opala, G., et al. (2008). Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients. Parkinsonism Relat. Disord. 14, 636-640. doi: 10.1016/j.parkreldis.2008.02.001
3. Brewer, G. J., Torricelli, J. R., Evege, E. K., and Price, P. J. (1993). Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35, 567-576. doi: 10.1002/jnr.490350513
4. Carrasco, E., Casper, D., and Werner, P. (2007). PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity. J. Neurosci. Res. 85, 3109-3117. doi: 10.1002/jnr.21425
5. Catterall, W. A. (2011). Voltage-gated calcium channels. Cold Spring Harb. Perspect. Biol. 3:a003947. doi: 10.1101/cshperspect.a003947
6. Chung, S., Leung, A., Han, B. S., Chang, M. Y., Moon, J. I., Kim, C. H., et al. (2009). Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway. Cell Stem Cell 5, 646-658. doi: 10.1016/j.stem.2009.09.015
7. Devine, M. J., Ryten, M., Vodicka, P., Thomson, A. J., Burdon, T., Houlden, H., et al. (2011). Parkinson's disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nat. Commun. 2, 440. doi: 10.1038/ncomms1453
8. Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., et al. (2006). In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol. Dis. 21, 404-412. doi: 10.1016/j.nbd.2005.08.002
9. Groden, D. L., Guan, Z., and Stokes, B. T. (1991). Determination of Fura-2 dissociation constants following adjustment of the apparent Ca-EGTA association constant for temperature and ionic strength. Cell Calcium 12, 279-287. doi: 10.1016/0143-4160(91)90002-V
10. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985). A new generation of indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
11. Harms, A. S., Barnum, C. J., Ruhn, K. A., Varghese, S., Trevino, I., Blesch, A., et al. (2011). Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease. Mol. Ther. 19, 46-52. doi: 10.1038/mt.2010.217
12. Hartley, B. J., Fabb, S. A., Finnin, B. A., Haynes, J. M., and Pouton, C. W. (2014). Zinc-finger nuclease enhanced gene targeting in human embryonic stem cells. J. Vis. Exp. 2014:e51764. doi: 10.3791/51764
13. Haynes, J. M., Iannazzo, L., and Majewski, H. (2002). Phorbol ester-induced contractility and influx in human cultured prostatic stromal cells. Biochem. Pharmacol. 64, 385-392. doi: 10.1016/S0006-2952(02)01211-X
14. Hockemeyer, D., Soldner, F., Beard, C., Gao, Q., Mitalipova, M., DeKelver, R. C., et al. (2009). Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851-857. doi: 10.1038/nbt.1562
15. Inglefield, J. R., and Schwartz-Bloom, R. D. (1999). Fluorescence imaging of changes in intracellular chloride in living brain slices. Methods 18, 197-203. doi: 10.1006/meth.1999.0772
16. Ji, H., Hougaard, C., Herrik, K. F., Strobaek, D., Christophersen, P., and Shepard, P. D. (2009). Tuning the excitability of midbrain dopamine neurons by modulating the sensitivity of SK channels. Eur. J. Neurosci. 29, 1883-1895. doi: 10.1111/j.1460-9568.2009.06735.x
17. Khaira, S. K., Nefzger, C. M., Beh, S. J., Pouton, C. W., and Haynes, J. M. (2011). Midbrain and forebrain patterning delivers immunocytochemically and functionally similar populations of neuropeptide Y containing GABAergic neurons. Neurochem. Int. 59, 413-420. doi: 10.1016/j.neuint.2011.02.016
18. Khaira, S. K., Pouton, C. W., and Haynes, J. M. (2009). P2X2, P2X4 and P2Y1 receptors elevate intracellular in mouse embryonic stem cell-derived GABAergic neurons. Br. J. Pharmacol. 158, 1922-1931. doi: 10.1111/j.1476-5381.2009.00479.x
19. Kim, J. H., Auerbach, J. M., Rodriguez-Gomez, J. A., Velasco, I., Gavin, D., Lumelsky, N., et al. (2002). Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418, 50-56. doi: 10.1038/nature00900
20. Kim, S. Y., Choi, K. C., Chang, M. S., Kim, M. H., Kim, S. Y., Na, Y. S., et al. (2006). The dopamine D2 receptor regulates the development of dopaminergic neurons via extracellular signal-regulated kinase and Nurr1 activation. J. Neurosci. 26, 4567-4576. doi: 10.1523/JNEUROSCI.5236-05.2006
21. Kim, S. H., Jang, J. Y., Jang, M., Um, K. B., Chung, S., Kim, H. J., et al. (2013). Homeostatic regulation mechanism of spontaneous firing determines glutamate responsiveness in the midbrain dopamine neurons. Cell Calcium 54, 295-306. doi: 10.1016/j.ceca.2013.07.004
22. Krapf, R., Berry, C. A., and Verkman, A. S. (1988). Estimation of intracellular chloride activity in isolated perfused rabbit proximal convoluted tubules using a fluorescent indicator. Biophys. J. 53, 955-962. doi: 10.1016/S0006-3495(88)83176-X
23. Kriks, S., Shim, J. W., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., et al. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480, 547-571. doi: 10.1038/nature10648
24. Lang, R. J., Haynes, J. M., Kelly, J., Johnson, J., Greenhalgh, J., O'Brien, C., et al. (2004). Electrical and neurotransmitter activity of mature neurons derived from mouse embryonic stem cells by Sox-1 lineage selection and directed differentiation. Eur. J. Neurosci. 20, 3209-3221. doi: 10.1111/j.1460-9568.2004.03782.x
25. Lindvall, O., Kokaia, Z., and Martinez-Serrano, A. (2004). Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 10(Suppl.), S42-S50. doi: 10.1038/nm1064
26. Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408. doi: 10.1006/meth.2001.1262
27. Luk, K. C., Rymar, V. V., van den Munckhof, P., Nicolau, S., Steriade, C., Bifsha, P., et al. (2013). The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress. J. Neurochem. 125, 932-943. doi: 10.1111/jnc.12160
28. Marinelli, M., Rudick, C. N., Hu, X. T., and White, F. J. (2006). Excitability of dopamine neurons: modulation and physiological consequences. CNS Neurol. Disord. Drug Targets 5, 79-97. doi: 10.2174/187152706784111542
29. Matsushita, N., Okada, H., Yasoshima, Y., Takahashi, K., Kiuchi, K., and Kobayashi, K. (2002). Dynamics of tyrosine hydroxylase promoter activity during midbrain dopaminergic neuron development. J. Neurochem. 82, 295-304. doi: 10.1046/j.1471-4159.2002.00972.x
30. McCoy, M. K., Martinez, T. N., Ruhn, K. A., Szymkowski, D. E., Smith, C. G., Botterman, B. R., et al. (2006). Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. 26, 9365-9375. doi: 10.1523/JNEUROSCI.1504-06.2006
31. McCoy, M. K., Ruhn, K. A., Martinez, T. N., McAlpine, F. E., Blesch, A., and Tansey, M. G. (2008). Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats. Mol. Ther. 16, 1572-1579. doi: 10.1038/mt.2008.146
32. Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., and Nagatsu, T. (1994). Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 165, 208-210. doi: 10.1016/0304-3940(94)90746-3
33. Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., et al. (2000). Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J. Neural. Transm. 107, 335-341. doi: 10.1007/s007020050028
34. Mogi, M., Togari, A., Tanaka, K., Ogawa, N., Ichinose, H., and Nagatsu, T. (1999). Increase in level of tumor necrosis factor (TNF)-alpha in 6-hydroxydopamine-lesioned striatum in rats without influence of systemic L-DOPA on the TNF-alpha induction. Neurosci. Lett. 268, 101-104. doi: 10.1016/S0304-3940(99)00388-2
35. Nagatsu, T., and Sawada, M. (2007). Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects. J. Neural Transm. Suppl. 2007, 113-120. doi: 10.1007/978-3-211-73574-9_14
36. Nefzger, C. M., Su, C. T., Fabb, S. A., Hartley, B. J., Beh, S. J., Zeng, W. R., et al. (2012). Lmx1a allows context-specific isolation of progenitors of GABAergic or dopaminergic neurons during neural differentiation of embryonic stem cells. Stem Cells 30, 1349-1361. doi: 10.1002/stem.1105
37. Nguyen, H. N., Byers, B., Cord, B., Shcheglovitov, A., Byrne, J., Gujar, P., et al. (2011). LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8, 267-280. doi: 10.1016/j.stem.2011.01.013
38. Nishimura, M., Mizuta, I., Mizuta, E., Yamasaki, S., Ohta, M., Kaji, R., et al. (2001). Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease. Neurosci. Lett. 311, 1-4. doi: 10.1016/S0304-3940(01)02111-5
39. Nunes, I., Tovmasian, L. T., Silva, R. M., Burke, R. E., and Goff, S. P. (2003). Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 100, 4245-4250. doi: 10.1073/pnas.0230529100
40. Overton, P. G., and Clark, D. (1997). Burst firing in midbrain dopaminergic neurons. Brain Res. Brain Res. Rev. 25, 312-334. doi: 10.1016/S0165-0173(97)00039-8
41. Payne, J. A., Rivera, C., Voipio, J., and Kaila, K. (2003). Cation-chloride co-transporters in neuronal communication, development and trauma. Trends Neurosci. 26, 199-206. doi: 10.1016/S0166-2236(03)00068-7
42. Raye, W. S., Tochon-Danguy, N., Pouton, C. W., and Haynes, J. M. (2007). Heterogeneous population of dopaminergic neurons derived from mouse embryonic stem cells: preliminary phenotyping based on receptor expression and function. Eur. J. Neurosci. 25, 1961-1970. doi: 10.1111/j.1460-9568.2007.05489.x
43. Rivera, C., Voipio, J., Payne, J. A., Ruusuvuori, E., Lahtinen, H., Lamsa, K., et al. (1999). The co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 397, 251-255. doi: 10.1038/16697
44. Sanchez-Danes, A., Consiglio, A., Richaud, Y., Rodriguez-Piza, I., Dehay, B., Edel, M., et al. (2012). Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells. Hum. Gene Ther. 23, 56-69. doi: 10.1089/hum.2011.054
45. Sarnat, H. B., and Flores-Sarnat, L. (2005). Embryology of the neural crest: its inductive role in the neurocutaneous syndromes. J. Child Neurol. 20, 637-643. doi: 10.1177/08830738050200080101
46. Smeyne, R. J., and Jackson-Lewis, V. (2005). The MPTP model of Parkinson's disease. Brain Res. Mol. Brain Res. 134, 57-66. doi: 10.1016/j.molbrainres.2004.09.017
47. Smidt, M. P., van Schaick, H. S., Lanctot, C., Tremblay, J. J., Cox, J. J., van der Kleij, A. A., et al. (1997). A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 94, 13305-13310. doi: 10.1073/pnas.94.24.13305
48. Smidt, M. P., von Oerthel, L., Hoekstra, E. J., Schellevis, R. D., and Hoekman, M. F. (2012). Spatial and temporal lineage analysis of a Pitx3-driven Cre-recombinase knock-in mouse model. PLoS ONE 7:e42641. doi: 10.1371/journal.pone.0042641
49. Snyder, S. H. (2011). What dopamine does in the brain. Proc. Natl. Acad. Sci. U.S.A. 108, 18869-18871. doi: 10.1073/pnas.1114346108
50. Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., and O'Callaghan, J. P. (2002). Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J. 16, 1474-1476.
51. Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., and O'Callaghan, J. P. (2006). Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. FASEB J. 20, 670-682. doi: 10.1096/fj.05-5106com
52. Thompson, L., Barraud, P., Andersson, E., Kirik, D., and Bjorklund, A. (2005). Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J. Neurosci. 25, 6467-6477. doi: 10.1523/JNEUROSCI.1676-05.2005
53. Wang, T., Pei, Z., Zhang, W., Liu, B., Langenbach, R., Lee, C., et al. (2005). induced COX-2 activation and subsequent dopaminergic neurodegeneration. FASEB J. 19, 1134-1136.
54. Watmuff, B., Pouton, C. W., and Haynes, J. M. (2012). In vitro maturation of dopaminergic neurons derived from mouse embryonic stem cells: implications for transplantation. PLoS ONE 7:e31999. doi: 10.1371/journal.pone.0031999
55. Wiedenmann, B., and Franke, W. W. (1985). Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41, 1017-1028. doi: 10.1016/S0092-8674(85)80082-9